Methotrexate and anti-tumor necrosis factor treatment improves endothelial function in patients with inflammatory arthritis

information on the effect of antirheumatic drugs on EF in AS and PsA patients is still limited. [...]the aim of this study was to compare EF in RA, AS, and PsA patients, and to examine the effect of antirheumatic treatment (MTX and/or anti-TNF) on EF in these patient groups. [...]the differences in RHI change between baseline and 6 months in the two treatment groups were independent of rheumatic disease duration, IA diagnosis, and age. [...]there were no statistically significant differences in the examined traditional CV risk factors, the occurrences of clinical CVD and ED, and median RHI val... Mehr ...